2 followers
Genomic analysis can distinguish malignant from benign myeloma precursors, refining progression risk predictions and treatment strategies. by Maura F, Bergsagel PL (...) Rajkumar SV et 41 al. in J Clin Oncol #MedSky 👉 get more here 📖 read the article…